Veerhealth Care Intrinsic Value
Veerhealth Care (VEERHEALTH) median intrinsic value is ₹15.00 from 8 valuation models (range ₹7–₹22), vs current price ₹23.34 — -35.7% downside (Trading Above Calculated Value), margin of safety -55.6%. Also explore Veerhealth Care stock price data download to track price trends across different timeframes.
VEERHEALTH Valuation Methods Summary — DCF, Graham Number & P/E
Veerhealth Care intrinsic value across 8 models vs current price ₹23.34 — upside/downside and value range per method. Browse VEERHEALTH income statement for revenue, profit, balance sheet and cash flow data.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹8.80 | ₹7.04 - ₹10.56 | -62.3% | EPS: ₹0.40, Sector P/E: 22x |
| Book Value Method | asset | ₹22.00 | ₹19.80 - ₹24.20 | -5.7% | Book Value/Share: ₹11.00, P/B: 2.0x |
| Revenue Multiple Method | revenue | ₹22.00 | ₹19.80 - ₹24.20 | -5.7% | Revenue/Share: ₹11.00, P/S: 2.0x |
| EBITDA Multiple Method | earnings | ₹15.00 | ₹13.50 - ₹16.50 | -35.7% | EBITDA: ₹3.00Cr, EV/EBITDA: 10x |
| Simple DCF (5Y) | dcf | ₹20.38 | ₹16.30 - ₹24.46 | -12.7% | CF Growth: 15.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹7.00 | ₹6.30 - ₹7.70 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹7.00 | ₹6.30 - ₹7.70 | -70.0% | Revenue Growth: 15.0%, Adj P/E: 16.1x |
| Graham Defensive Method | conservative | ₹9.95 | ₹8.96 - ₹10.95 | -57.4% | EPS: ₹0.40, BVPS: ₹11.00 |
VEERHEALTH Intrinsic Value vs Market Price — All Valuation Models
Veerhealth Care fair value range ₹7–₹22 vs current market price ₹23.34 across 8 valuation models. For current market price and key ratios, visit VEERHEALTH stock price BSE.
VEERHEALTH Intrinsic Value Analysis — Undervalued or Overvalued?
Veerhealth Care median intrinsic value ₹15.00, current price ₹23.34 — Trading Above Calculated Value by 35.7%, margin of safety -55.6%.
What is the intrinsic value of VEERHEALTH?
Based on our comprehensive analysis using 8 different valuation methods, the estimated intrinsic value of Veerhealth Care (VEERHEALTH) is ₹15.00 (median value). With the current market price of ₹23.34, this represents a -35.7% variance from our estimated fair value.
The valuation range spans from ₹7.00 to ₹22.00, indicating ₹7.00 - ₹22.00.
Is VEERHEALTH undervalued or overvalued?
Based on our multi-method analysis, Veerhealth Care (VEERHEALTH) appears to be trading above calculated value by approximately 35.7%.
VEERHEALTH Financial Health — Key Ratios vs Industry Benchmarks
Veerhealth Care financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 1.38 | Industry Standard: 2.0+ | Below 1.5 | Measures short-term liquidity capacity |
| Return on Equity | 4.5% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | 7.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.65x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
VEERHEALTH Cash Flow Quality — Operating & Free Cash Flow
Veerhealth Care operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹0 Cr | ₹-4 Cr | Negative Cash Flow | 3/10 |
| March 2024 | ₹3 Cr | ₹3 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹-1 Cr | ₹-2 Cr | Negative Cash Flow | 3/10 |
| March 2022 | ₹2 Cr | ₹2 Cr | Positive Free Cash Flow | 8/10 |
| March 2021 | ₹1 Cr | ₹1 Cr | Positive Free Cash Flow | 8/10 |